The Maryland Life Sciences, a division of the Maryland Tech Council, brings together vaccine leaders to discuss current breakthroughs in the world of vaccines and immunotherapeutics. This breakfast meeting will address innovating strategies to meet current health threats, changing technology for vaccine manufacturing and provide a snapshot of where vaccine development stands today.
Join us for breakfast, networking and a discussion to hear about the experiences and insights on the current state and projected future of treatments. Local leaders will also discuss challenges and opportunities that come with vaccine and immunotherapy development used by companies in our State.
Moderator
Steve Hoffman, M.D.
Chief Executive Officer and Chief Scientific Officer
Sanaria
Speakers:
Jeff Galvin
Chief Executive Officer and Founder
American Gene Technologies
Sally Mossman
Vice President, Head Discovery Performance Unit
GSK
Kelly Lyn Warfield, Ph.D.
Vice President, Vaccine and Anti-infectives Research and Development
Emergent BioSolutions
